NasdaqGS:ANABBiotechs
How Do AnaptysBio’s (ANAB) Jemperli Royalties Shape Its Investment Case After Tesaro’s Claim Dismissal?
AnaptysBio recently reported that the Delaware Chancery Court dismissed Tesaro’s anticipatory breach of contract claim over their Jemperli collaboration, while CEO Daniel Faga is set to discuss the company’s royalty assets at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on May 6, 2026.
This legal outcome, combined with a stronger earnings outlook highlighted by an upgraded Zacks rank, strengthens AnaptysBio’s position around its Jemperli-related royalty rights.
We’ll now...